AAAAAA
Results: 1-25/34
Authors:
Khan, J
Wei, JS
Ringner, M
Saal, LH
Ladanyi, M
Westermann, F
Berthold, F
Schwab, M
Antonescu, CR
Peterson, C
Meltzer, PS
Citation: J. Khan et al., Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks, NAT MED, 7(6), 2001, pp. 673-679
Authors:
Bauer, A
Savelyeva, L
Claas, A
Praml, C
Berthold, F
Schwab, M
Citation: A. Bauer et al., Smallest region of overlapping deletion in I p36 in human neuroblastoma: AI Mbp cosmid and PAC contig, GENE CHROM, 31(3), 2001, pp. 228-239
Authors:
Creutzig, U
Ritter, J
Zimmermann, M
Reinhardt, D
Hermann, J
Berthold, F
Henze, G
Jurgens, H
Kabisch, H
Havers, W
Reiter, A
Kluba, U
Niggli, F
Gadner, H
Citation: U. Creutzig et al., Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: Results of study Acute Myeloid Leukemia - Berlin-Frankfurt-Munster 93, J CL ONCOL, 19(10), 2001, pp. 2705-2713
Authors:
Creutzig, U
Berthold, F
Boos, J
Fleischhack, G
Gadner, H
Gnekow, A
Graubner, U
Henze, G
Hermann, J
Imbach, P
Jurgens, H
Kabisch, H
Korholz, D
Niemeyer, CM
Reinhardt, D
Reiter, A
Ritter, J
Spaar, HJ
Zimmermann, M
Citation: U. Creutzig et al., Improved treatment results in children with AML: Results of study AML-BFM 93, KLIN PADIAT, 213(4), 2001, pp. 175-185
Traditional and emerging molecular markers in neuroblastoma prognosis: Thegood, the bad and the ugly
Authors:
Poremba, C
Hero, B
Goertz, HG
Scheel, C
Wai, D
Schaefer, KL
Christiansen, H
Berthold, F
Juergens, H
Boecker, W
Dockhorn-Dworniczak, B
Citation: C. Poremba et al., Traditional and emerging molecular markers in neuroblastoma prognosis: Thegood, the bad and the ugly, KLIN PADIAT, 213(4), 2001, pp. 186-190
Authors:
Simon, T
Voth, E
Berthold, F
Citation: T. Simon et al., Asymmetric salivary gland I-123-meta-iodobenzylguanidine uptake in a patient with cervical neuroblastoma and Horner syndrome, MED PED ONC, 36(4), 2001, pp. 489-490
Authors:
Ladenstein, R
Ambros, IM
Potschger, U
Amann, G
Urban, C
Fink, FM
Schmitt, K
Jones, R
Slociak, M
Schilling, F
Ritter, J
Berthold, F
Gadner, H
Ambros, PF
Citation: R. Ladenstein et al., Prognostic significance of DNA di-tetraploidy in neuroblastoma, MED PED ONC, 36(1), 2001, pp. 83-92
Authors:
Hedborg, F
Franklin, G
Norrman, J
Grimelius, L
Wassberg, E
Hero, B
Schilling, F
Berthold, F
Harms, D
Sandstedt, B
Citation: F. Hedborg et al., Evidence of chromaffin oxygen sensing in neuroblastoma, MED PED ONC, 36(1), 2001, pp. 149-153
Authors:
Manzke, O
Russello, O
Leenen, C
Diehl, V
Bohlen, H
Berthold, F
Citation: O. Manzke et al., Immunotherapeutic strategies in neuroblastoma: Antitumoral activity of deglycosylated ricin A conjugated anti-CD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies, MED PED ONC, 36(1), 2001, pp. 185-189
Preclinical and clinical aspects on the use of amifostine as chemoprotectorin neuroblastoma patients
Authors:
Fulda, S
Fichtner, I
Hero, B
Berthold, F
Citation: S. Fulda et al., Preclinical and clinical aspects on the use of amifostine as chemoprotectorin neuroblastoma patients, MED PED ONC, 36(1), 2001, pp. 199-202
Authors:
Hero, B
Hunneman, DH
Gahr, M
Berthold, F
Citation: B. Hero et al., Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma, MED PED ONC, 36(1), 2001, pp. 220-223
Authors:
Koch, A
Waha, A
Tonn, JC
Sorensen, N
Berthold, F
Wolter, M
Reifenberger, J
Hartmann, W
Friedl, W
Reifenberger, G
Wiestler, OD
Pietsch, T
Citation: A. Koch et al., Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors, INT J CANC, 93(3), 2001, pp. 445-449
Authors:
Dahmen, RP
Koch, A
Denkhaus, D
Tonn, JC
Sorensen, N
Berthold, F
Behrens, J
Birchmeier, W
Wiestler, OD
Pietsch, T
Citation: Rp. Dahmen et al., Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas, CANCER RES, 61(19), 2001, pp. 7039-7043
Authors:
Geoerger, B
Hero, B
Harms, D
Grebe, J
Scheidhauer, K
Berthold, F
Citation: B. Geoerger et al., Metabolic activity and clinical features of primary ganglioneuromas, CANCER, 91(10), 2001, pp. 1905-1913
Authors:
Przkora, R
Meyer-Puttlitz, B
Schmitt, O
Berthold, F
Nothen, M
Krauss, J
Tonn, JC
von Deimling, A
Wiestler, OD
Pietsch, T
Citation: R. Przkora et al., Analysis of the TSC2 gene in human medulloblastoma, ACT NEUROP, 102(4), 2001, pp. 380-384
Authors:
Muller, S
van den Boom, D
Zirkel, D
Koster, H
Berthold, F
Schwab, M
Westphal, M
Zumkeller, W
Citation: S. Muller et al., Retention of imprinting of the human apoptosis-related gene TSSC3 in humanbrain tumors, HUM MOL GEN, 9(5), 2000, pp. 757-763
Authors:
Poremba, C
Scheel, C
Hero, B
Christiansen, H
Schaefer, KL
Nakayama, J
Berthold, F
Juergens, H
Boecker, W
Dockhorn-Dworniczak, B
Citation: C. Poremba et al., Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: A molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues, J CL ONCOL, 18(13), 2000, pp. 2582-2592
Authors:
Kortmann, RD
Kuhl, J
Timmermann, B
Mittler, U
Urban, C
Budach, V
Richter, E
Willich, N
Flentje, M
Berthold, F
Slavc, I
Wolff, J
Meisner, C
Wiestler, O
Sorensen, N
Warmuth-Metz, M
Bamberg, M
Citation: Rd. Kortmann et al., Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT '91, INT J RAD O, 46(2), 2000, pp. 269-279
Authors:
Sjoholm, E
Gustafsson, K
Berthold, F
Colmsjo, A
Citation: E. Sjoholm et al., Influence of the carbohydrate composition on the molecular weight distribution of kraft pulps, CARBOHY POL, 41(1), 2000, pp. 1-7
Authors:
Poremba, C
Hero, B
Heine, B
Scheel, C
Schaefer, KL
Christiansen, H
Berthold, F
Kneif, S
Stein, H
Juergens, H
Boecker, W
Dockhorn-Dworniczak, B
Citation: C. Poremba et al., Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas, MED PED ONC, 35(6), 2000, pp. 651-655
Authors:
Hero, B
Simon, T
Horz, S
Berthold, F
Citation: B. Hero et al., Metastatic neuroblastoma in infancy: What does the pattern of metastases contribute to prognosis?, MED PED ONC, 35(6), 2000, pp. 683-687
Authors:
Schilling, FH
Berthold, F
Erttmann, R
Michaelis, J
Spix, C
Sander, J
Schwarz, K
Treuner, J
Citation: Fh. Schilling et al., Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: Interim results, MED PED ONC, 35(6), 2000, pp. 701-704
Authors:
Berthold, F
Herick, K
Siewe, RM
Citation: F. Berthold et al., Luminometer design and low light detection, METH ENZYM, 305, 2000, pp. 62-87
Authors:
Berthold, F
Hero, B
Citation: F. Berthold et B. Hero, Neuroblastoma - Current drug therapy recommendations as part of the total treatment approach, DRUGS, 59(6), 2000, pp. 1261-1277
Authors:
Simon, T
Hero, B
Berthold, F
Citation: T. Simon et al., Testicular and paratesticular involvement by metastatic neuroblastoma, CANCER, 88(11), 2000, pp. 2636-2641